Clinical trials
Phase 1/2 Mesothelioma, Malignant trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
43 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 2 |
| 2012 | 2 |
| 2013 | 1 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 3 |
| 2019 | 2 |
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 5 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Recruiting | 10 |
| Terminated | 7 |
| Active, not recruiting | 4 |
| Unknown status | 3 |
| Not yet recruiting | 2 |
| Suspended | 1 |
| Enrolling by invitation | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 4 |
| University Hospital, Antwerp | 4 |
| TCR2 Therapeutics | 2 |
| University Health Network, Toronto | 2 |
| 7 Hills Pharma, LLC | 1 |
| A2 Biotherapeutics Inc. | 1 |
| Aminex Therapeutics, Inc. | 1 |
| Armando Santoro, MD | 1 |
| Beijing Biotech | 1 |
| CRISPR Therapeutics AG | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mesothelioma, Malignant | 43 |
| Carcinoma, Non-Small-Cell Lung | 13 |
| Mesothelioma | 10 |
| Neoplasms | 8 |
| Carcinoma, Renal Cell | 7 |
| Colorectal Neoplasms | 7 |
| Esophageal Neoplasms | 7 |
| Endometrial Neoplasms | 5 |
| Neoplasm Metastasis | 5 |
| Ovarian Neoplasms | 5 |
Trials
Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.